Zydus Lifesciences Limited has informed the Exchange about General Updates

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.7%1-day move

₹878.90

prior close

₹883.25

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-0.9-0.7-1.1-1.7-1.2-0.6+1.6+2.5+4.8+5.5+3.0+23.9+26.2

Up moveDown movePending

AI summary

Zydus Lifesciences has received a demand order from the Assistant Commissioner of Central GST, Ambala, for the financial years 2019-20 to 2023-24. The order, passed under Section 74 of the CGST/HGST Act, 2017, pertains to the alleged reversal of inadmissible Input Tax Credit and includes demand, interest, and penalty totalling Rs. 14.20 million. The order was received on March 31, 2026. The company has stated that it believes it has strong grounds and intends to appeal against the order.

Likely market impact

The demand amount of Rs. 14.20 million is small relative to Zydus Lifesciences' overall business, and the company has confirmed there is no material financial impact. Shareholders are unlikely to see a meaningful effect on the stock from this order alone, though the appeal outcome bears watching.